Author Archives: Kristin Berry, George N. Ioannou

The main concern of Mehta et al, and Vitale et al, is that we might have over-estimated the waitlist life expectancy of patients with HCC who have low MELD scores. This concern, which is addressed below, does not change any of the conclusions of the … Continue reading →

Patients with T2 hepatocellular carcinoma (HCC) can obtain an exception that allows them to undergo liver transplantation with much lower actual Model for End-Stage Liver Disease (MELD) scores than patients without HCC. We compared patients who receive… Continue reading →